EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Vitamin K2 and Cardiovascular Calcification: Mechanistic Foundations, Conflicting Clinical Evidence, and Unresolved Questions

Chinmayi Kothari, Rahul Chowdhary, Sada Babazade iD, Alexander Egoavil iD, Wajeh Abuirmaileh, Samir R Kapadia, Sunil J Wimalawansa iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27219645 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Chinmayi Kothari und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, OH 44195, USA. Hauptthemen laut MEDLINE: Vitamin K 2, Vascular Calcification. Die Arbeit nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiovascular calcification is an active, complex process involving osteogenic transformation, inflammation, extracellular vesicle release, and impaired mineral buffering. These changes result from mineral imbalance and reduced levels of calcification inhibitors. Vitamin K supports the γ-carboxylation of matrix Gla protein (MGP) and other mineralization inhibitors, though some calcification defenses do not depend on vitamin K. Vitamin K deficiency and warfarin therapy increase circulating dephosphorylated-uncarboxylated MGP (dp-ucMGP), which is linked to greater vascular calcification. Preclinical studies demonstrate that disruption of the vitamin K-MGP axis promotes calcification. Supplementation with vitamin K1 or K2 can reduce, prevent, or partially reverse mineralization in certain animal models. In contrast, evidence from human studies is less consistent. Observational studies have identified an association between menaquinone (vitamin K2) intake and cardiovascular outcomes, but causality has not been established. Most randomized trials have shown neutral results for aortic-valve and chronic kidney disease-associated calcification, while the VitaK-CAC and DANCODE studies reported slower progression of coronary artery calcium in selected populations with moderate or severe baseline coronary calcification. These discrepancies may be due to differences in calcification phenotypes, disease stage, vitamin K forms, dosing regimens, vitamin D status, renal function, and response to vitamin K antagonists such as warfarin. Coronary intimal, valvular, and arterial medial calcification should be regarded as phenotypically distinct entities. This review evaluates the mechanistic, preclinical, and clinical evidence linking vitamin K2 to cardiovascular calcification and highlights population groups that warrant further clinical investigation. Large, adequately powered, and phenotype-specific clinical trials are needed to determine whether appropriately dosed vitamin K2 is a safe and cost-effective intervention for slowing valvular and vascular calcification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vitamin K 2Vascular CalcificationHumansAnimalsMatrix Gla ProteinExtracellular Matrix ProteinsCalcium-Binding ProteinsVitamin K

Stichwörter der Autor:innen

bioprostheticcoronary artery calciummatrix Gla protein (MGP)valve calcificationvalve degeneration

Substanzen

Vitamin K 2Matrix Gla ProteinExtracellular Matrix ProteinsCalcium-Binding ProteinsVitamin K

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
  • Department of Internal Medicine, Cleveland Clinic, Cleveland, OH 44195, USA.
  • Department of Medicine, Cardiometabolic & Endocrine Institute, North Brunswick, NJ 08902, USA.

ORCID-Profile: Sada Babazade, Alexander Egoavil, Sunil J Wimalawansa

Zitieren

APA

Kothari, C., Chowdhary, R., Babazade, S., Egoavil, A., Abuirmaileh, W., Kapadia, S. R., & Wimalawansa, S. J. (2026). Vitamin K2 and Cardiovascular Calcification: Mechanistic Foundations, Conflicting Clinical Evidence, and Unresolved Questions. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27219645

Vancouver

Kothari C, Chowdhary R, Babazade S, Egoavil A, Abuirmaileh W, Kapadia SR, et al. Vitamin K2 and Cardiovascular Calcification: Mechanistic Foundations, Conflicting Clinical Evidence, and Unresolved Questions. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27219645

BibTeX
@article{Kothari2026,
  author = {Kothari, Chinmayi and Chowdhary, Rahul and Babazade, Sada and Egoavil, Alexander and Abuirmaileh, Wajeh and Kapadia, Samir R and Wimalawansa, Sunil J},
  title = {Vitamin K2 and Cardiovascular Calcification: Mechanistic Foundations, Conflicting Clinical Evidence, and Unresolved Questions},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27219645}
}
Kostenlos starten →